BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27015839)

  • 21. Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing.
    Jiang Y; Qiu Y; Minn AJ; Zhang NR
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5528-37. PubMed ID: 27573852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral morphological heterogeneity can be an indicator of genetic heterogeneity in colorectal cancer.
    Büttner J; Jöhrens K; Klauschen F; Hummel M; Lenze D; Saeger W; Lehmann A
    Exp Mol Pathol; 2018 Feb; 104(1):76-81. PubMed ID: 29337243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer.
    Suzuki Y; Ng SB; Chua C; Leow WQ; Chng J; Liu SY; Ramnarayanan K; Gan A; Ho DL; Ten R; Su Y; Lezhava A; Lai JH; Koh D; Lim KH; Tan P; Rozen SG; Tan IB
    Mol Oncol; 2017 Feb; 11(2):124-139. PubMed ID: 28145097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare germline copy number variants in colorectal cancer predisposition characterized by exome sequencing analysis.
    Franch-Expósito S; Esteban-Jurado C; Garre P; Quintanilla I; Duran-Sanchon S; Díaz-Gay M; Bonjoch L; Cuatrecasas M; Samper E; Muñoz J; Ocaña T; Carballal S; López-Cerón M; Castells A; ; Vila-Casadesús M; Derdak S; Laurie S; Beltran S; Carvajal J; Bujanda L; Ruiz-Ponte C; Camps J; Gironella M; Lozano JJ; Balaguer F; Cubiella J; Caldés T; Castellví-Bel S
    J Genet Genomics; 2018 Jan; 45(1):41-45. PubMed ID: 29396139
    [No Abstract]   [Full Text] [Related]  

  • 25. Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing.
    Wu H; Zhang XY; Hu Z; Hou Q; Zhang H; Li Y; Li S; Yue J; Jiang Z; Weissman SM; Pan X; Ju BG; Wu S
    Oncogene; 2017 May; 36(20):2857-2867. PubMed ID: 27941887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early mutation bursts in colorectal tumors.
    Zhao J; Salomon MP; Shibata D; Curtis C; Siegmund K; Marjoram P
    PLoS One; 2017; 12(3):e0172516. PubMed ID: 28257429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.
    Cajuso T; Hänninen UA; Kondelin J; Gylfe AE; Tanskanen T; Katainen R; Pitkänen E; Ristolainen H; Kaasinen E; Taipale M; Taipale J; Böhm J; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P
    Int J Cancer; 2014 Aug; 135(3):611-23. PubMed ID: 24382590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel.
    Sato KA; Hachiya T; Iwaya T; Kume K; Matsuo T; Kawasaki K; Abiko Y; Akasaka R; Matsumoto T; Otsuka K; Nishizuka SS
    PLoS One; 2016; 11(1):e0146275. PubMed ID: 26727500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas.
    Ishii M; Sugai T; Habano W; Nakamura S
    J Gastroenterol; 2004 Jun; 39(6):544-9. PubMed ID: 15235871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer.
    Kondo Y; Hayashi K; Kawakami K; Miwa Y; Hayashi H; Yamamoto M
    BMC Cancer; 2017 May; 17(1):311. PubMed ID: 28468669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
    Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer.
    Tórtola S; Steinert R; Hantschick M; Peinado MA; Gastinger I; Stosiek P; Lippert H; Schlegel W; Reymond MA
    J Clin Oncol; 2001 Jun; 19(11):2837-43. PubMed ID: 11387355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole exome sequencing and single nucleotide polymorphism array analyses to identify germline alterations in genes associated with testosterone metabolism in a patient with androgen insensitivity syndrome and early-onset colorectal cancer.
    Disciglio V; Devecchi A; Palumbo O; Carella M; Penso D; Milione M; Valle G; Pierotti MA; Vitellaro M; Bertario L; Canevari S; Signoroni S; De Cecco L
    Chin J Cancer; 2016 Jun; 35(1):51. PubMed ID: 27267075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data.
    Fan Y; Xi L; Hughes DS; Zhang J; Zhang J; Futreal PA; Wheeler DA; Wang W
    Genome Biol; 2016 Aug; 17(1):178. PubMed ID: 27557938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determining the origin of synchronous multifocal bladder cancer by exome sequencing.
    Acar Ö; Özkurt E; Demir G; Saraç H; Alkan C; Esen T; Somel M; Lack NA
    BMC Cancer; 2015 Nov; 15():871. PubMed ID: 26553077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples.
    Dallol A; Buhmeida A; Al-Ahwal MS; Al-Maghrabi J; Bajouh O; Al-Khayyat S; Alam R; Abusanad A; Turki R; Elaimi A; Alhadrami HA; Abuzenadah M; Banni H; Al-Qahtani MH; Abuzenadah AM
    J Transl Med; 2016 May; 14(1):118. PubMed ID: 27146902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic heterogeneity in primary colorectal carcinomas and their metastases: born bad or brought up a villain?
    Hühns M; Krohn S; Murua Escobar H; Prall F
    Hum Pathol; 2018 Apr; 74():54-63. PubMed ID: 29307628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].
    Zhang HP; Fu L; Chen PQ; Ye YB; Ji TH; Zheng LM
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):757-61. PubMed ID: 21215167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P53 mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients.
    Khan ZA; Jonas SK; Le-Marer N; Patel H; Wharton RQ; Tarragona A; Ivison A; Allen-Mersh TG
    Clin Cancer Res; 2000 Sep; 6(9):3499-504. PubMed ID: 10999735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiregional Tumor Trees Are Not Phylogenies.
    Alves JM; Prieto T; Posada D
    Trends Cancer; 2017 Aug; 3(8):546-550. PubMed ID: 28780931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.